Bortenat - Bortezomib for Injection is prescribed for treating mantle cell lymphoma and multiple myeloma. Advanced formulation of this injection prevents proliferation of cancer affected cells. Its dosage depends on health condition of patients. Patients suffering from kidney, liver and heart disease or bleeding problem should take special care before its administering. Bortenat - Bortezomib for Injection is used as an integral part of chemotherapy. Standard of this medication has been tested on the basis of its shelf life, composition, packaging type, effectiveness, long lastingness of result and possible side effects.